We examined the effect of -58 C/T and BE1 +9/-9 polymorphisms in the bradykinin B2 receptor gene on forearm vascular resistance (FVR) before and during intrabrachial artery infusion of the B2 receptor-, endothelium-dependent agonist bradykinin and the endothelium-independent agonist sodium nitroprusside in 228 normotensive subjects. In 166 white Americans, systolic blood pressure (SBP) and pulse pressure were highest in the BE1 +9/+9 group (118+/-2 and 51+/-2 mm Hg, respectively;
After 100 years of measurement, reasons for interindividual and populational variation in blood pres...
AbstractTissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) directly i...
The bradykinin B2 receptor (B2R) gene is a candidate in the pathogenesis of insulin resistance, whic...
To test the hypothesis that the bradykinin receptor 2 (BDKRB2) BE1+9/-9 polymorphism affects vascula...
The contribution of kinins to the beneficial effects in cardiovascular risk reductions remains uncle...
The efficacy of the ACE (angiotensin-converting enzyme) inhibitor perindopril in coronary artery dis...
The efficacy of the ACE (angiotensin-converting enzyme) inhibitor perindopril in coronary artery dis...
Background: Pulmonary arterial pressure (PAP) varies considerably in heart failure (HF) despite simi...
Objective: Hypertension, which affects 25% of the world's population, is a complex disease, with 30%...
<div><h3>Background</h3><p>Research has shown that bradykinin β<sub>2</sub> receptor (<em>BDKRB2</em...
BACKGROUND: Research has shown that bradykinin β(2) receptor (BDKRB2) -58T/C gene polymorphism is co...
Aims The contribution of kinins to the beneficial effects of angiotensin I converting enzyme (ACE) i...
Background: Physiological pathways such as bradykinin, renin-angiotensin, neurohormones and nitric o...
Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) directly influence...
The BK (bradykinin) B2 receptor is the major cellular mediator of the effects of BK. A 9 bp del...
After 100 years of measurement, reasons for interindividual and populational variation in blood pres...
AbstractTissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) directly i...
The bradykinin B2 receptor (B2R) gene is a candidate in the pathogenesis of insulin resistance, whic...
To test the hypothesis that the bradykinin receptor 2 (BDKRB2) BE1+9/-9 polymorphism affects vascula...
The contribution of kinins to the beneficial effects in cardiovascular risk reductions remains uncle...
The efficacy of the ACE (angiotensin-converting enzyme) inhibitor perindopril in coronary artery dis...
The efficacy of the ACE (angiotensin-converting enzyme) inhibitor perindopril in coronary artery dis...
Background: Pulmonary arterial pressure (PAP) varies considerably in heart failure (HF) despite simi...
Objective: Hypertension, which affects 25% of the world's population, is a complex disease, with 30%...
<div><h3>Background</h3><p>Research has shown that bradykinin β<sub>2</sub> receptor (<em>BDKRB2</em...
BACKGROUND: Research has shown that bradykinin β(2) receptor (BDKRB2) -58T/C gene polymorphism is co...
Aims The contribution of kinins to the beneficial effects of angiotensin I converting enzyme (ACE) i...
Background: Physiological pathways such as bradykinin, renin-angiotensin, neurohormones and nitric o...
Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) directly influence...
The BK (bradykinin) B2 receptor is the major cellular mediator of the effects of BK. A 9 bp del...
After 100 years of measurement, reasons for interindividual and populational variation in blood pres...
AbstractTissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) directly i...
The bradykinin B2 receptor (B2R) gene is a candidate in the pathogenesis of insulin resistance, whic...